tiprankstipranks
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS

Apellis Pharmaceuticals (APLS) Balance Sheet

723 Followers

Apellis Pharmaceuticals Balance Sheet

Apellis Pharmaceuticals's total assets for Q3 2023 were $818.22M, a decrease of -10.64% from the previous quarter. APLS total liabilities were $585.95M for the fiscal quarter, a 2.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 760.19M$ 881.76M$ 960.57M$ 389.25M$ 203.53M
Total Liabilities
$ 590.35M$ 683.10M$ 756.01M$ 355.02M$ 42.56M
Total Equity Gross Minority
$ 178.73M$ 198.66M$ 204.56M$ 34.23M$ 160.97M
Total Capitalization
$ 484.64M$ 387.69M$ 563.39M$ 176.80M$ 186.35M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 18.90M$ 14.47M$ 0.00
Currency in USD

Apellis Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis